BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 64126)

  • 1. [Immunologic abnormalities during treatment with penicillamine].
    Recordier AM; Roux H; Mercier P; Maestracci D; Schiano A
    Ann Med Interne (Paris); 1976 AUG-SEP; 127(8-9):566-70. PubMed ID: 64126
    [No Abstract]   [Full Text] [Related]  

  • 2. [D-penicillamine induced lupus during the treatment of rheumatoid arthritis. Report of 2 cases and systematic immunologic study during the treatment].
    Crouzet J; Camus JP; Leca AP; Guillien P; Lièvre JA
    Ann Med Interne (Paris); 1974 Jan; 125(1):71-9. PubMed ID: 4136184
    [No Abstract]   [Full Text] [Related]  

  • 3. Frequent induction of insulin autoantibodies by D-penicillamine in patients with rheumatoid arthritis.
    Vardi P; Brik R; Barzilai D; Lorber M; Scharf Y
    J Rheumatol; 1992 Oct; 19(10):1527-30. PubMed ID: 1464863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myasthenia during treatment of rheumatoid polyarthritis with D-penicillamine].
    Carter H; Job-Deslandre C; Delrieu F; Menkes CJ
    Therapie; 1984; 39(6):689-95. PubMed ID: 6531741
    [No Abstract]   [Full Text] [Related]  

  • 5. Autoantibody formation in D-penicillamine-treated rheumatoid arthritis.
    Camus JP; Homberg JC; Crouzet J; Mery C; Delrieu F; Massias P; Abuaf N
    J Rheumatol Suppl; 1981; 7():80-3. PubMed ID: 6939887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [D-penicillamine in the treatment of patients with rheumatoid arthritis].
    Gracheva GV; Erov NK; Romanovskaia LR
    Ter Arkh; 1983; 55(9):94-8. PubMed ID: 6605592
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pemphigus induced by D-penicillamine in rheumatoid arthritis. Study of 5 cases and systematic study of anti-intercellular substance antibodies of the skin in the course of treatment].
    Benveniste M; Crouzet J; Homberg JC; Lessana M; Camus JP; Hewitt J
    Nouv Presse Med; 1975 Dec; 4(44):3125-8. PubMed ID: 1220709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibodies to D-penicillamine in patients with chronic polyarthritis--diagnostic aid in undesired and insufficient drug effects?].
    Storch W; Keitel W
    Z Rheumatol; 1988; 47 Suppl 1():44-7. PubMed ID: 3213272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penicillamine induced polymyositis and dermatomyositis.
    Carroll GJ; Will RK; Peter JB; Garlepp MJ; Dawkins RL
    J Rheumatol; 1987 Oct; 14(5):995-1001. PubMed ID: 3501473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myasthenia gravis and autoimmune thyroiditis during the treatment of rheumatoid polyarthritis withD-penicillamine. Anatomoclinical study of 1 case].
    Delrieu F; Menkes CJ; Sainte-Croix A; Babinet P; Chesneau AM; Delbarre F
    Ann Med Interne (Paris); 1976 Oct; 127(10):739-43. PubMed ID: 1008366
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acetylcholine receptor antibody in D-penicillamine therapy].
    Kolarz G; Maida EM
    Z Rheumatol; 1986; 45(3):118-21. PubMed ID: 3751350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polymyositis induced by D-penicillamine treatment of rheumatoid arthritis: apropos of 2 cases with antinuclear antibodies].
    Masson CJ; Ménard HA; Audran M; Renier JC; Lussier A; Myhal DM
    Union Med Can; 1986 Dec; 115(12):855-9. PubMed ID: 3492802
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic studies of D-penicillamine in the treatment of rheumatoid arthritis.
    Payne RW; Cahill CL
    J Okla State Med Assoc; 1969 Oct; 62(10):487-91. PubMed ID: 5406880
    [No Abstract]   [Full Text] [Related]  

  • 14. [D-penicillamine in the treatment of rheumatoid arthritis].
    Gerloni V; Colombo B; Carraière G
    Reumatismo; 1977; 29(2-3):157-62. PubMed ID: 616962
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of Cuprenil (D-penicillamine) treatment in patients with rheumatoid arthritis].
    Maldykowa H; Chwalińska-Sadowska H; Luft S; Glińska-Urban D; Mikolajew M; Odrzywolska A; Jaworska H
    Reumatologia; 1972; 10(1):9-21. PubMed ID: 5019762
    [No Abstract]   [Full Text] [Related]  

  • 16. [D-penicillamine induced myasthenic syndromes in rheumatoid arthritis. Two cases (author's transl)].
    Rodat O; Hamelin JP; Rossard A; Cottin S; Cler JM; Rodat G; Lemouroux P
    Nouv Presse Med; 1981 May; 10(20):1645-8. PubMed ID: 7255126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinico-immunological analysis of D-penicillamine use in rheumatoid arthritis].
    Benenson EV; Alibekova RI; Seĭsenbaev ASh; Cherkasskiĭ LA; Ivanova RL
    Vopr Revm; 1980; (4):27-31. PubMed ID: 6972667
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-term results of D-penicillamine treatment in rheumatoid arthritis].
    Kutsuna T; Maeda K; Okamoto T
    Ryumachi; 1986 Aug; 26(4):270-7. PubMed ID: 3563727
    [No Abstract]   [Full Text] [Related]  

  • 19. Penicillamine treatment of rheumatoid arthritis: relationship of proteinuria and autoantibodies to immune status.
    Zilko PJ; Dawkins RL; Cohen ML
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):118-22. PubMed ID: 122657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Our experience in the treatment of rheumatoid polyarthritis with D-penicillamine].
    Valat JP; Neveur CA; Le Chevallier PL
    Rev Rhum Mal Osteoartic; 1978 Feb; 45(2):121-7. PubMed ID: 644236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.